| 764298 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
961 Preliminary results of a phase 2 study of intratumoral administration of BO-112 with pembrolizumab in patients with advanced melanoma that have progressive disease on anti-PD-1-based therapy |
2021-11-01 |
10.1136/jitc-2021-sitc2021.961 |
Rodas Iván Márquez, Saiag Philippe, Merino Luis de la Cruz, Dutriaux Caroline, Rodríguez-Moreno Juan, Robert Caroline, Arance Ana, Álvarez Eduardo Castañón, Cerezuela-Fuentes Pablo, Montaudie Henry, Sanmamed Miguel, Cao María González, Charles Julie, López Criado María Pilar, Berrocal Alfonso, Miguel Enrique de, Funk-Brentano Elisa, Prey Sorilla, Huertas Roberto, Abreu Delvys Rodríguez, Couselo Eva Muñoz, Martin-Liberal Juan, López Javier Sánchez, Escuin-Ordinas Helena, Quintero Marisol, Maciá Sonia, Chaney Marya, Dalle Stephane |
| 764297 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
507 A phase 1 clinical trial of RP2, an enhanced potency oncolytic HSV expressing an anti-CTLA-4 antibody, as a single agent and combined with nivolumab in patients with advanced solid tumors |
2021-11-01 |
10.1136/jitc-2021-sitc2021.507 |
Middleton Mark, Sacco Joseph, Harrington Kevin, Olsson-Brown Anna, Chan Tze, Nenclares Pablo, Leslie Isla, Aroldi Francesca, Bommareddy Praveen, Saleem Imran, Castro Henry, Pirzkall Andrea, Coffin Robert |
| 764296 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
403 Correlative analysis of blood and biopsy samples from a clinical trial of Hsp90 inhibition in combination with pembrolizumab reveals increased intratumoral myeloid cell accumulation after treatment |
2021-11-01 |
10.1136/jitc-2021-sitc2021.403 |
Herting Cameron, Zhang Yuchen, Doxie Deon, Ware Michael, Alese Olatunji, Wu Christina, Akce Mehmet, Zaidi Mohammad, Ruggieri Amanda, Dhodapkar Madhav, Dhodapkar Kavita, Sarmiento Juan, Ahmed Rafi, Maithel Shishir, El-Rayes Bassel, Lesinski Gregory |
| 764295 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
241 Immune checkpoint blockade (ICB) in brain metastases (BM) from advanced small cell urothelial cancer (aSCUC) |
2021-11-01 |
10.1136/jitc-2021-sitc2021.241 |
Wilson Nathaniel, Alhalabi Omar, Hasanov Elshad, Xiao Lianchun, Papadopoulos John, Campbell Matthew, Shah Amishi, Gao Jianjun, Corn Paul, Aparicio Ana, Wang Jennifer, Czerniak Bogdan, Guo Charles, Logothetis Christopher, Li Jing, Choi Seungtaek, Tang Chad, Tannir Nizar, Siefker-Radtke Arlene |
| 764294 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
459 Phase 3 study of first-line pembrolizumab with and without vibostolimab (anti-TIGIT) in patients with PD-L1–positive metastatic NSCLC |
2021-11-01 |
10.1136/jitc-2021-sitc2021.459 |
Hellmann Matthew, Cho Byoung, Juergens Rosalyn, Cheng Ying, Castro Gilberto de, Erman Mustafa, Bauman Jessica, Takahashi Toshiaki, Schwarzenberger Paul, Zhang Pingye, Catherine Pietanza M, Yang James Chih-Hsin |
| 764293 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
567 Isoform specific anti-TGFβ therapy enhances antitumor efficacy in mouse models of stroma poor cancers |
2021-11-01 |
10.1136/jitc-2021-sitc2021.567 |
Budhu Sadna, Gupta Aditi, Fitzgerald Kelly, Giese Rachel, Michel Adam, Holland Aliya, Campesato Luis Felipe, Snick Jacques Van, Uyttenhove Catherine, Ritter Gerd, Wolchok Jedd, Merghoub Taha |
| 764292 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
653 The immune landscape of primary and recurrent adolescent and young adult bone sarcomas |
2021-11-01 |
10.1136/jitc-2021-sitc2021.653 |
Cillo Anthony, Mukherjee Elina, Daley Jessica, Onkar Sayali, Li Xiang, Liu Dongyan, Vignali Dario, Bruno Tullia, Bailey Kelly |
| 764291 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
148 Primary or iPSC-derived cell-based cytotoxicity assays to assess potential safety risks of engineered T cell therapies in vitro |
2021-11-01 |
10.1136/jitc-2021-sitc2021.148 |
Vermond Sophie, Hazenoot Monique, McLaughlin Rene, Munnik Sabrina de, Guadagnoli Marco, Moiset Gemma, Holt Sanne, Vlaming Marijn |
| 764290 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
5 CD274 (PD-L1) gene expression and the 27-gene immuno-oncology (IO) assay are associated with efficacy to immune checkpoint inhibitor treated patients with non-small cell lung cancer (NSCLC) |
2021-11-01 |
10.1136/jitc-2021-sitc2021.005 |
Nielsen Tyler, Varga Matthew, McGregor Kim, Ross Douglas, Schweitzer Brock, Seitz Rob, Vidal Gregory |
| 764289 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
4 3D Coculture platform reveals insights into patient autologous immune cell-tumor interaction and immune modulation in vitro |
2021-11-01 |
10.1136/jitc-2021-sitc2021.004 |
Kaushik Garima, Wesa Amy |
